Skip to content

KRAIG BIOCRAFT LABORATORIES, INC.: 10-Q filed 2016-11-14

What KRAIG BIOCRAFT LABORATORIES, INC. reported in its quarterly report filed 2016-11-14 (fiscal Q3 2016): 29 published measures, 74 facts as tagged in accession 0001654954-16-004009.

This filing

Form
10-Q (quarterly report)
Filed
2016-11-14
Fiscal period
fiscal Q3 2016
Accession
0001654954-16-004009 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All KRAIG BIOCRAFT LABORATORIES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2016-09-30412,396USD
At 2015-12-31304,937USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2016-09-302,677,513USD
At 2015-12-312,201,873USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2016-09-30-2,265,117USD
At 2015-12-31-1,896,936USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2016-09-30335,909USD
At 2015-12-31238,188USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2016-07-01 to 2016-09-30-1,124,468USD92
2016-01-01 to 2016-09-30-2,161,512USD274
2015-07-01 to 2015-09-30-348,515USD92
2015-01-01 to 2015-09-30-1,732,944USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2016-01-01 to 2016-09-30-824,791USD274
2015-01-01 to 2015-09-30-685,099USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2016-01-01 to 2016-09-302,488USD274
2015-01-01 to 2015-09-3039,285USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2016-01-01 to 2016-09-30925,000USD274
2015-01-01 to 2015-09-30450,000USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2016-01-01 to 2016-09-30-2,488USD274
2015-01-01 to 2015-09-30-39,285USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2016-09-30-22,473,648USD
At 2015-12-31-20,312,136USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2016-07-01 to 2016-09-300USD92
2016-01-01 to 2016-09-300USD274
2015-07-01 to 2015-09-300USD92
2015-01-01 to 2015-09-300USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2016-09-3055,953USD
At 2015-12-3166,104USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2016-07-01 to 2016-09-30-1,089,129USD92
2016-01-01 to 2016-09-30-2,067,774USD274
2015-07-01 to 2015-09-30-322,806USD92
2015-01-01 to 2015-09-30-1,670,235USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2016-09-30356,433USD
At 2015-12-31238,833USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2016-07-01 to 2016-09-3035,339USD92
2016-01-01 to 2016-09-3099,442USD274
2015-07-01 to 2015-09-3025,709USD92
2015-01-01 to 2015-09-3071,435USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2016-09-302,677,513USD
At 2015-12-312,201,873USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2016-09-3018,673USD
At 2015-12-310USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2016-07-01 to 2016-09-301,107,802USD92
2016-01-01 to 2016-09-302,086,447USD274
2015-07-01 to 2015-09-30322,806USD92
2015-01-01 to 2015-09-301,670,235USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2016-07-01 to 2016-09-30129,282USD92
2016-01-01 to 2016-09-30379,815USD274
2015-07-01 to 2015-09-3090,650USD92
2015-01-01 to 2015-09-30313,739USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2016-09-30767,952,594shares
At 2015-12-31708,068,385shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2016-09-302,219,520USD
At 2015-12-312,373,458USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2016-09-3031,629USD
At 2015-12-3118,989USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2016-09-302,042,642USD
At 2015-12-311,666,748USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2016-07-01 to 2016-09-30821,651USD92
2016-01-01 to 2016-09-301,046,324USD274
2015-07-01 to 2015-09-3054,990USD92
2015-01-01 to 2015-09-30854,517USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2016-01-01 to 2016-09-3012,639USD274
2015-01-01 to 2015-09-3011,175USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2016-07-01 to 2016-09-30-35,339USD92
2016-01-01 to 2016-09-30-93,738USD274
2015-07-01 to 2015-09-30-25,709USD92
2015-01-01 to 2015-09-30-62,709USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2016-01-01 to 2016-09-30875,000USD274
2015-01-01 to 2015-09-30450,000USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2016-01-01 to 2016-09-30-18,673USD274
2015-01-01 to 2015-09-300USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2016-01-01 to 2016-09-3044,338USD274
2015-01-01 to 2015-09-3070,950USD273

Inspect the source

Entity
KRAIG BIOCRAFT LABORATORIES, INC. / CIK 0001413119
Captured
2026-09-20T08:02:08.774Z
SEC response SHA-256
920795b2181369f3ae04be68b2de22ae3d9ee7808a72922b976f9dc124464bc6

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001413119.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))